These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31771774)

  • 1. [Advances in sickle cell disease treatments: Towards targeted therapies].
    Arlet JB
    Rev Med Interne; 2020 Feb; 41(2):73-77. PubMed ID: 31771774
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new therapeutic era in sickle cell disease].
    Arlet JB
    Rev Med Interne; 2017 Sep; 38(9):569-571. PubMed ID: 28624233
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusing children with hemoglobinopathies.
    Allali S; Taylor M; Albinni S; Amiranoff D; de Montalembert M
    Transfus Clin Biol; 2019 Sep; 26(3):147-149. PubMed ID: 31300265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging disease-modifying therapies for sickle cell disease.
    Carden MA; Little J
    Haematologica; 2019 Sep; 104(9):1710-1719. PubMed ID: 31413089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.
    Lebensburger JD; Pestina TI; Ware RE; Boyd KL; Persons DA
    Haematologica; 2010 Sep; 95(9):1599-603. PubMed ID: 20378564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in sickle cell therapies in the hydroxyurea era.
    Field JJ; Nathan DG
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S37-42. PubMed ID: 25549232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating sickle cell anemia: A new era dawns.
    Steinberg MH
    Am J Hematol; 2020 Apr; 95(4):338-342. PubMed ID: 31925819
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.
    Amrolia PJ; Almeida A; Halsey C; Roberts IA; Davies SC
    Br J Haematol; 2003 Mar; 120(5):725-36. PubMed ID: 12614202
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advances in sickle cell disease in the last decade.
    Shet AS; Thein SL
    Indian J Med Res; 2017 Jun; 145(6):708-712. PubMed ID: 29067969
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy for sickle cell disease.
    The Lancet Haematology
    Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in the Treatment of Sickle Cell Disease.
    Kapoor S; Little JA; Pecker LH
    Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving treatment landscape for children with sickle cell disease.
    Jacob SA; Talati R; Kanter J
    Lancet Child Adolesc Health; 2023 Nov; 7(11):797-808. PubMed ID: 37858508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Homozygous Sickle Cell Children Treated with Hydroxyurea in Brazzaville (Congo)].
    Mabiala-Babela JR; Nika ER; Ikobo LCO; Gnakingue ANO; Ngoulou BPS; Mandilou SVM
    Bull Soc Pathol Exot; 2019; 112(4):206-212. PubMed ID: 32003197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.
    Dover GJ; Charache S
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):61-6. PubMed ID: 1379374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell anemia: targeting the role of fetal hemoglobin in therapy.
    Coleman E; Inusa B
    Clin Pediatr (Phila); 2007 Jun; 46(5):386-91. PubMed ID: 17556734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell anemia therapy: progress since Pauling.
    Schechter AN; Rodgers GP
    Science; 2000 Jan; 287(5453):592-3. PubMed ID: 10691539
    [No Abstract]   [Full Text] [Related]  

  • 20. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
    Bauer DE; Brendel C; Fitzhugh CD
    Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.